Among the various T-ALL oncogenic alterations reported to date, gain-of-function alterations in transcriptional factors such as LYL1, HOXA, TAL1, TLX1, and TLX3 represent a recurrent oncogenic hallmark of T-ALL [27]. The gene discussed is LYL1; the disease is acute lymphoblastic leukemia.